DMAC — DIAMEDICA THERAPEUTICS INC

Ownership history in CATALYST FINANCIAL PARTNERS LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which CATALYST FINANCIAL PARTNERS LLC reported a position in DIAMEDICA THERAPEUTICS INC (DMAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2023 Q2)
Avg. % of fund
0.03%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 38,457 — 0% 0.03% $306K $7.96
2025 Q3 UNCHANGED 38,457 — 0% 0.03% $264K $6.87
2025 Q2 UNCHANGED 38,457 — 0% 0.02% $150K $3.90
2025 Q1 UNCHANGED 38,457 — 0% 0.03% $146K $3.79
2024 Q4 UNCHANGED 38,457 — 0% 0.04% $209K $5.43
2024 Q3 UNCHANGED 38,457 — 0% 0.03% $161K $4.19
2024 Q2 ADDED 38,457 +2,190 +6.0% 0.02% $113K $2.95
2024 Q1 UNCHANGED 36,267 — 0% 0.02% $94K $2.77
2023 Q4 UNCHANGED 36,267 — 0% 0.03% $103K $2.84
2023 Q3 UNCHANGED 36,267 — 0% 0.03% $94K $2.58
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DMAC price (monthly, adj. close)

Other funds also holding DMAC

As of 2025 Q4 — sorted by position size

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 3Y 7Y 14.39% Bleichroeder LP 3Y 0.54% COOPERMAN LEON G 3Y 7Y 0.53% MAGNOLIA CAPITAL ADVISORS LLC 3Y 0.13% Informed Momentum Co LLC 3Y 7Y 0.08% Private Capital Management, LLC 3Y 7Y 0.04% AXQ CAPITAL, LP 3Y 0.02% Truvestments Capital LLC 3Y 7Y 0.01% Meridian Wealth Management, LLC 3Y 7Y 0.01% Stonebridge Capital Advisors LLC 3Y 7Y 0.01%
← Back to CATALYST FINANCIAL PARTNERS LLC Holdings